A Long-term Follow-up Study of Patients Who Received MB-105
Categories (click each to see list of all clinical trials associated with that category): Cellular Therapy Support Service - Other CAR (ONC), FPBCC CTO Studies, Lymphoma/CLL (ONC)
Current Status: Open
Phase: N/A
Principal Investigator: Vose, Julie
Contact Information:
Susan Blumel, RN
402-559-9183
sblumel@unmc.edu
Eligibility: https://clinicaltrials.gov/study/NCT07340814?term=MB-105-202&rank=1#participation-criteria
Summary
Primary: Assess long term safety of MB-105 in patients who received MB-105 in an interventional March Biosciences-sponsored study
Secondary: Evaluate the risk of secondary malignancies after MB-105 treatment
Assess long term efficacy of MB-105